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ABSTRACT 
 
Background: The purpose of this paper is to systematically review the studies 
which look at the risk of cardiac function on patients with known coronary artery 
disease during travel to higher altitudes. The body of evidence will be evaluated 
using the Grading of Recommendations Assessment, Development and 
Evaluation (GRADE) tool developed by the GRADE Working Group. 
 
Method: An exhaustive literature search was performed using PubMed, Medline, 
CINHAL and Web of Science through the Pacific University Library system. The 
following keywords were searched individually and in combination: coronary 
artery disease, (CAD), altitude, travel.  
 
Results:  Two studies were reviewed on this topic. The first study reviewed 22 
patients and reported a resting heart rate increase of 19% at 3454m compared to 
that at low altitude. Maximum O2 uptake at 3454m decreased significantly going 
from 28.3 ml/kg/min at sea level to 22.9 ml/kg/min at altitude. Another study was 
a case control study that took 10 healthy nonacclimatized male controls and eight 
non acclimatized men with CAD and measured rate pressure products (RPP) a 
clinical indicator of myocardial oxygen. The RPP increased significantly at rest in 
hypoxic conditions and the ECG evaluation had four out the eight CAD patients 
with significant ST-segment depression, whereas all eight patients had ST-
depression at simulated altitude 
 
Conclusion: CAD patients should be advised traveling to altitude with rest and 
exercise is a risk. The grade score was moderate for these studies. 
 
Keywords:  coronary artery disease, CAD, altitude, travel  
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INTRODUCTION 
Background 
 
Annually an estimated 35 million tourists visit the Western United States, 
40 million visit the Alps and there are over 100 million tourists worldwide 
(Burtscher et al., 2001). Traveling to mountainous regions is becoming more of a 
leisure time activity for the whole family and may include skiing, hiking and 
mountain climbing. Visiting mountainous regions offers a wide range of outside 
entertainment that can be enjoyed by healthy people as well as those with 
chronic health conditions.  
One of the top five health issues today is coronary artery disease (CAD). 
According to the World Health Organization (WHO, 2011) coronary vascular 
disease ranks as number one in death of adults in the world.   
CAD is defined as a narrowing of the small blood vessels that supply 
blood and oxygen to the heart. This can lead to myocardial infarctions (MI), 
stable and unstable angina and even death. The concern for patients with CAD is 
the lack of blood and oxygen flow to the heart tissue in essence depriving the 
heart muscle of what it needs most. When traveling to higher altitudes the 
demand on the heart muscle takes on more stress for increasing oxygen to areas 
where it is needed. When moving from sea level to high altitude, there are 
reductions in atmospheric pressure, oxygen pressure, humidity, and temperature 
(Higgins, 2010).  Wyss et al. (2003) observed a significant decrease in exercise 
induced coronary flow reserve in CAD patients during inhalation of a hypoxic gas 
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mixture corresponding to an altitude of 2500m compared with baseline 
measurements at 450m. This would suggest that patients with CAD and/or a 
history of cardiac events may have to work harder with limited resources in order 
to compensate for the change in altitude. The responsibility of the heart is 
hindered by the lower oxygen pressure at altitude that is needed for maintaining 
stability in the body during this time of transition to higher altitude. Lower oxygen 
pressure means the heart is being stressed, and tries to compensate for that, by 
working harder. The heart beats faster and pumps harder trying to increase more 
oxygen to the tissue, but there is only so much oxygen the heart can bring in, due 
to the limited oxygen carrying capacity of hemoglobin that is found within red 
blood cells of patients at sea level. So more red blood cells are produced which 
increases volume load on the heart thereby increasing more cells moving 
through the already narrowed arteries which can potentially result in an MI.  
 Flow is linked to oxygen demand.  This is necessary because the heart 
has very high basal oxygen consumption (8-10 ml O2/min/100g) and the highest 
A-VO2 difference of a major organ (10-13 ml/100 ml) (Klabunde, 2007).  In non-
diseased coronary vessels, whenever cardiac activity and oxygen consumption 
increases, there is an increase in coronary blood flow (active hyperemia) that is 
nearly proportionate to the increase in oxygen consumption (Klabunde, 2007). 
Adenosine is an important go-between of increased blood flow and auto 
regulation. It serves as a metabolic link between oxygen consumption and 
coronary blood flow (Klabunde, 2007).  
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 Limiting or conflicting information has been given on the topic of traveling 
to high altitude (defined as greater than 500m) and having a prior cardiac event 
such as an (MI). Conflicting results show that living at high altitude with CAD 
actually helps in lowering an MI event where as another study showed living at 
high altitude was an environmental risk factor (Baibas, Trichopoulou, Voridis, & 
Trichopoulos, 2005; Al-Huthi, Raja'a, Al-Noami, & Rahman, 2006). With CAD 
patients who live at high altitude there was a 15 year cohort study from 1981 to 
1996 by Baibas, et al. (2005) there were 1198 inhabitants (504 men & 646 
women) that were researched to see if there was a relation to total and coronary 
mortality for residence in mountainous versus lowland areas within Greece. This 
study took into account multiple variables including, age, smoking, drinking, 
systolic blood pressure, glucose, cholesterol, uric acid and cell volume. Coronary 
cumulative mortality was somewhat lower among the mountainous village 
residents than among lowland residents.  
One study cautiously recommends performing physical exercise even at 
moderate altitude (Wyss et al., 2003) and yet, another study suggests that 
residents in mountainous regions with increased activity under moderate hypoxia 
seemed to have a “protective effect” from total and coronary mortality (Baibas et 
al., 2005). A recommendation from (Tuttle et al. 2010) states both ascending to 
altitude and exercising at altitude can be safe in patients with stable coronary 
artery disease or a remote history of an acute coronary event.  
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PURPOSE  
The purpose of this paper is to systematically review the effect that 
traveling to higher altitudes has on the cardiac function of patients with known 
CAD. In addition, the body of evidence will be evaluated using the Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) tool 
developed by the GRADE Working Group (Guyatt et al., 2008) 
 
 
METHOD 
 
An extensive literature search was performed using PubMed, Medline, 
CINHAL and Web of Science through the Pacific University Library system. The 
following keywords were searched individually and in combination: coronary 
artery disease (CAD), altitude, travel. The search was limited to the English 
language, results published since 2000 and human subjects. This resulted in 17 
articles. Duplicates, narrative reviews, editorials and letters to the editor were 
excluded. The remaining six articles were included in this systematic review 
involving randomized trials and cohort studies. Studies were taken from all over 
the world. 
  
RESULTS  
 The first study reviewed was performed by Schmid et al., (2006) who 
enrolled 22 patients with a history of an MI to be revascularized either by 
percutaneous coronary angioplasty or by coronary bypass surgery. All 
participants underwent eight to10 weeks of cardiac rehab following their MI. They 
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were then given a stress test at 540m in Switzerland and then rapidly ascended a 
railway to simulate the “touristic” approach for altitude which brought the 
participants up to 3454m. At this altitude they were given another stress test to 
compare to the original stress test. All beta blocker medicines were held for one 
week to give maximal effect of stress testing. The authors reported a resting 
heart rate increase of 19% at 3454m compared to that at low altitude (Schmid et 
al., 2006). In correlation to maximum oxygen uptake(VO2 max), which is the 
body’s ability to transport and use O2 during aerobic activity, this increased 
equally during sub maximal exercise at both altitudes but at 3454m it decreased 
significantly going from 28.3 ml/kg/min at sea level to 22.9 ml/kg/min at altitude. 
Lactate levels, levels showing hypoxia in the blood, were also taken at two 
minute intervals which showed marginal differences until  six minutes which 
indicated a significant increase at altitude of 3.4 (Range .5-2.2 mmol/L) 
compared to that of 2.3 (Range .5-2.2 mmol/L) at sea level. At peak, lactate 
levels were actually higher at sea level (7.1) than at altitude (6.9) but not shown 
to be of statistical significance (p=0.715). Despite these changes, no 
complications were observed and no stress tests had to be stopped prematurely. 
No evidence of stress induced ischemia or arrhythmias were noted during the 
stress test and recovery (Schmid et al., 2006).  
 The next study reviewed was conducted by Wyss et al. (2003) who 
studied the “Influence of Altitude Exposure on Coronary Flow Reserve.” This was 
a case control study that took 10 healthy nonacclimatized male controls and eight 
non acclimatized men with CAD and simulated hypoxic conditions during rest, 
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adenosine stress testing and exercise. The healthy controls were simulating 
altitude at 4500 m where as the CAD patients would simulate altitude at 2500 m. 
 One of the outcomes measured was rate pressure products (RPP); a 
clinical indicator of myocardial oxygen demand is calculated by multiplying the 
heart rate by the systolic blood pressure. The RPP in both groups increased 
significantly at rest in hypoxic conditions. However, when adenosine was 
introduced into the equation, hypoxia was more pronounced in CAD patients. 
RPP had no significant change at maximal exercise in normoxia and hypoxia. 
With ECG evaluations, four out the eight CAD patients had significant ST-
segment depression, whereas all eight patients had ST-depression at simulated 
altitude, two patients experienced angina pain at baseline, but seven did so at 
altitude (Wyss et al., 2003). The authors reported that myocardial blood flow 
(MBF) in controls at altitude had a 24% increase compared to that at baseline 
which was similar to that of the CAD participants. When exercise was introduced 
there was a 38% increase in reserve coronary blood flow (CBF) for controls 
whereas for CAD patients it actually decreased 18%. There seemed to be no 
significant change for either the CAD or control patients when adenosine was 
introduced into the study. 
DISCUSSION 
 Clinicians should be able to advise patients on the effects of travelling to 
higher altitudes. Taking into account different studies is important because it 
gives a perspective of how to best treat the patient and what one can do for 
recommendations. Data was used for traveling from high to low altitude with use 
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of exercise and rest to give the best possible information for the treatment of a 
patient. This systematic review has attempted to answer what effect a change in 
altitude can have for CAD patients, giving the practitioner the best 
knowledgeable answer to give a patient. Could a practitioner have confidence in 
counseling a CAD patient for traveling to higher altitude? 
 Schmid et al. (2006) studied patients with stable CAD going to high 
altitudes. This study confirmed stress put on the heart by comparing rest and 
exercise at sea level and higher elevation which could potentiate ischemia or an 
acute MI event. 
  Stress was put on the heart just at rest in higher elevations, in which the 
heart rate increased 19%. This would indicate a compensatory mechanism by 
the heart for O2 when someone with CAD is taken to altitude. The body is 
adjusting its supply and demand for the decreased O2 on the myocardial tissue. 
This study did take into consideration removing beta blocker medications in order 
to get maximal effort out of the injured heart from the participants; this could 
possibly help understand why there was such an increased heart rate in CAD 
participants. 
 In exercise testing, increased systolic BP at different stages signified 
increased heart tissue demand. When hypoxic conditions arise, sympathetic 
responses occur and can cause coronary vasoconstriction in regions with 
abnormal endothelial vasomotor control and can further compromise myocardial 
oxygen delivery (Wyss et al., 2003). With increased BP and increased 
sympathetic response it would seem reasonable to advise BP control especially 
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during an activity that involves exercise. The decrease in O2 of 19% suggests 
that there would be a limited supply of O2 on an already damaged heart and 
tissues. With an increase in heart rate and then a lower pressure of O2 for 
tissues it would seem rational to suggest there is another risk factor in traveling 
at elevation. Increased lactate blood levels coincide with lower partial pressure at 
altitude and a decrease in O2 uptake on the heart. All these variables indicate 
stress on the heart and there is a decrease of O2 in the blood with increased 
stress in an elevated location to supply the heart  
 There were some limitations in this study (Baibas et al., 2005). The first 
being that only lactate blood samples were taken and no hematocrit or 
hemoglobin levels were sampled. These samples would help specify levels of 
capacity to carry O2. Although not specified, it is possible that not all patients 
were from the same climate. “Living in a mountainous village as compared with 
residence in the lowland ones exhibited an apparent “protective” effect…” 
(Baibas et al., 2005 p.276). Having a patient from a higher altitude in which they 
are already acclimatized and exercising them at an elevation that they are used 
to would result in the reported numbers being less significant. Second, they had 
taken patients, revascularized them with bypass surgery or angioplasty and 
rehabilitated them for 8-10 weeks, there were no indications of other co-
morbidities, and Schmid et al. (2006) stated that the data do not apply to patients 
at a higher risk than that of the population studied. This suggests that patients 
with lower ejection fraction, left ventricular dysfunction, with incomplete 
revascularization or not consistently rehabilitated may not benefit from the 
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findings of this study. Third, patients who did participate in this study were limited 
to 20 men and two women not giving us help on what to recommend for women 
when approached with this question. Future studies should deal with men and 
women more equally. Last, the study was also in a controlled environment with 
professionals on hand to maintain and monitor stress levels. It is possible that the 
estimate of effects given could be underestimated due to the controlled 
environment. Exposure to outside influences such as weather could have impact 
on the patient’s well being.  
 Wyss et al. (2003) studied the information for CAD patients at moderate 
altitude of 2500m as opposed to the control group at 4500m using rest, 
adenosine and exercise induced hypoxia. The rate pressure product (RPP) with 
sea level versus high elevation is significantly higher at rest for both control and 
CAD participants. This is indicating that there is a demand for myocardial O2. 
After adenosine was introduced to CAD participants, a medicine that decreases 
the heart rate in a high altitude versus low altitude simulation, the RPP was found 
to be significant representing an increase in demand for O2 on the heart. Two 
explanations are still possible on this, first, one can still have a flow of blood to 
the areas of the heart, but in a hypoxic condition have a decrease of O2 being 
delivered to tissue. Second, it is also possible that MBF was exhausted due to a 
decrease in coronary flow rate. Partial pressure is a key factor when a patient is 
taken to a higher elevation.  
 Some limitations of the present study were noted (Wyss et al, 2003). First, 
the participants were using a bicycle stress test as opposed to the treadmill 
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stress test which is not typical physical activity in the mountains. Hiking, downhill 
skiing and even walking around town are the typical touristic forms of movement. 
Maximal workload may have been limited by this scenario of the bike to achieve 
a capacity equal of that to travelers at higher elevations. Second, it was stated in 
the article that “Data was acquired in the post exercise period” (Wyss et al. 
2003). This circumstance of data collection would indicate that maximal output of 
hemodynamics had fallen before the data was obtained. The time period for 
participants to stop exercising and the time period to collect data would decrease 
actual information due to the recovery state of the participant. Lastly, the mean 
age for controls was 23 whereas the mean age for CAD patients was 56 and no 
women were involved in this study. The younger age of the control group could 
result in the difference in their numbers without any other consideration. If 
participants in the control group were better matched to the actual participants in 
age the numbers would have been closer in MBF and RPP.  
 During this review, the GRADE classification was used evaluate the 
quality of evidence in the studies. The outcomes reviewed were increased stress 
on the heart at rest and with exercise at high altitudes. The observational studies 
assisted in the findings of high versus low elevation stress on the heart for CAD 
patients in both exercise and at rest. Two studies qualified to be in the low quality 
category based on a case control study as well as a cohort study. 
The quality of evidence is classified by the GRADE Working Group into 
one of four levels: very low, low, moderate, and high.  The interpretation of each 
classification is as follows:  
15 
 
   High quality— Further research is very unlikely to change our 
confidence in the estimate of effect  
   Moderate quality— Further research is likely to have an important 
impact on our confidence in the estimate of effect and may change the 
estimate  
   Low quality— Further research is very likely to have an important 
impact on our confidence in the estimate of effect and is likely to change 
the estimate  
Very low quality— any estimate of effect is very uncertain (Guyatt et al., 
2008, 926).  
  
The outcomes evaluated in this review are increased stress on the heart 
at rest and with exercise (Appendix, Table 1). For the outcome measurement of 
increased stress on the heart at rest, two observational studies were evaluated. 
The two observational studies had a starting grade of low but were upgraded 
based on controlling of confounders. The resulting grade for the outcome was 
moderate, indicating that the two studies presented had enough of a comparison 
in their results to be of value in medical decision making.  
For the outcome of increased stress on the heart with exercise, two 
observational studies were evaluated. The first was a cohort study by Schmid et 
al. (2006) which studied the methods of exercise and rest at sea level and at 
elevation the second was from Wyss et al. (2003) which was a case-control study 
using exposure to altitude in determining coronary reserve.  
The overall GRADE across both outcomes was determined to be 
moderate with the upgrading of the confounders. This is interpreted to mean that 
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these sources were reliable and could be used to rely on in this question of 
traveling to high altitudes with CAD. 
  This study set out to find a legitimate answer to the question “Would it be 
a risk to send a patient to higher elevation knowing that they have CAD?” This 
topic is clinically relevant since there are multiple family members with CAD 
going to higher elevations for leisure time activities including walking and 
exercise. As patients proceed to higher elevations there is an increase in partial 
pressure that stresses the heart for maximal uptake of O2 and increases heart 
rate to deliver blood to the body and tissues. This stress on the heart could 
potentiate a cardiac event for that CAD patient. There is a risk in traveling to 
higher altitudes according to the studies reviewed.CAD patients should be given 
the information for risks involved when traveling to higher elevations and should 
take precautions. Furthermore, those with CAD should be advised to refrain from 
exercising at higher elevations. Each patient is different and should be 
considered to have specific needs met before advising them to proceed to higher 
altitude. The Grade supported certain reliability in the results of the studies by 
assessing a moderate score. Increasing research is likely to have an important 
impact in the estimate of effect and may change the estimate.  
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